That uptick, in part, was supported by Israeli-based generic drug giant Teva Pharmaceuticals Industries’ recent unsolicited $40 billion offer to buy smaller rival Mylan.
Thomson Reuters data shows that deals worth $194 billion have been announced in healthcare this year.
More articles on hospital transactions and valuation issues:
UC San Diego, Scripps Health collaborate in hospice care, training and research
3 reasons hospitals are avoiding mergers and choosing to affiliate instead
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
